Genetic Testing for Hereditary Colorectal Cancer
About 3% of colorectal cancer cases are due to an inherited condition known as Lynch syndrome. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP™) Working Group recommends that all people with a new diagnosis of colorectal cancer should be offered counseling and educational materials about genetic testing for Lynch syndrome.
Lynch Syndrome
Other Information
Although the EGAPP recommendation did not address use of testing in other situations, people with colorectal cancer diagnosed in the past (especially under age 50), and/or people with several family members with colorectal and/or uterine cancer may also benefit from genetic evaluation for Lynch syndrome.
In addition to talking with your health care provider, the Web sites below provide additional information on colorectal cancer, Lynch syndrome, cancer genetic testing, and access to genetic counseling services.
- Colorectal Cancer, Centers for Disease Control and Prevention
- Lynch Syndrome, Genetics Home Reference, U.S. National Library of
Medicine - Understanding Cancer Series: Gene Testing, National Cancer Institute
- Cancer Genetic Services Directory, National Cancer Institute
- Find-A-Counselor, National Society of Genetic Counselors
About 3% of colorectal cancer cases are due to an inherited condition known as Lynch syndrome (sometimes referred to as hereditary nonpolyposis colorectal cancer or HNPCC). People with this condition have a greatly increased chance of developing colorectal cancer, especially at a young age (younger than 50 years). Children, sisters, and brothers of people with Lynch syndrome have a 50% chance of inheriting this condition. Parents and other blood relatives such as grandparents, aunts, uncles, nieces and nephews are also at increased risk to have Lynch syndrome.
Genetic Testing for Lynch Syndrome
Genetic testing is used to find out if a person's colorectal cancer is hereditary (caused by an inherited gene change), so that family members can learn if they are also at increased risk. This could help to protect them from getting this disease.
The Evaluation of Genomics in Practice and Prevention (EGAPP™) Working Group found good scientific evidence to show that if individuals with colorectal cancer are found through genetic testing to have Lynch syndrome, their family members can benefit:
- by undergoing genetic testing to learn if they are also at increased genetic risk.
- by having earlier and more frequent screening which can prevent colorectal cancer, if the person is positive for the gene change.
The EGAPP Working Group concluded that all people with a new diagnosis of colorectal cancer should be offered counseling and educational materials about genetic testing for Lynch syndrome. Learn more.
The EGAPP™ Working Group is an independent, non-governmental panel of scientists and health care experts from universities, industry, clinical practice, insurance companies, and public health who review available research and evidence to make recommendations about the use of genetic tests.
By CDC
del.icio.us |
Digg
Email to a friend
Print version
Plain text
Home
Set as homepage
Add to favorites
Mobile site
Rss
Plain text
Archive
Post your comment